Australia vs Philippines: Previously treated cases tested for RR-/MDR-TB
Australia
76.0%
in 2024
Philippines
76.0%
in 2024
Australia rank
120th
Philippines rank
120th
Previously treated cases tested for RR-/MDR-TB over time
- Australia
- Philippines
How they compare
Australia currently reports 76.0% against 76.0% in Philippines, a difference of 0.0%.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Australia ahead.
Australia ranks 120th and Philippines ranks 120th of 180 countries.
Across the 2 decades both report, Australia averaged higher in 1 and Philippines in 1.
Head to head by decade
| Decade | Australia | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 72.0% | 47.7% | 24.3% | Australia |
| 2020s | 73.2% | 90.4% | 17.2% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Australia or Philippines?
- Australia, at 76.0% against 76.0% in Philippines as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Australia and Philippines?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Philippines?
- 15 years are reported by both, from 2010 to 2024.
- How do Australia and Philippines rank globally for previously treated cases tested for rr-/mdr-tb?
- Australia ranks 120th and Philippines ranks 120th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.